| scholarly article | Q13442814 |
| P50 | author | Dimas Covas | Q37366804 |
| Simone Kashima | Q55271568 | ||
| Evandra Strazza Rodrigues | Q56860574 | ||
| P2093 | author name string | Marco Antonio Zago | |
| Rochele Azevedo | |||
| Rodrigo Haddad | |||
| Patrícia Vianna Bonini Palma | |||
| Danielle Aparecida Rosa de Magalhães | |||
| P2860 | cites work | Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding | Q24338693 |
| RNA interference directs innate immunity against viruses in adult Drosophila | Q24551516 | ||
| Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses | Q24797827 | ||
| Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans | Q27860867 | ||
| Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells | Q27860926 | ||
| The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV | Q28184983 | ||
| RNA silencing as a plant immune system against viruses | Q28210891 | ||
| Treatment of HTLV-I-Associated Myelopathy / Tropical Spastic Paraparesis: Towards Rational Targeted Therapy | Q28972318 | ||
| Illuminating the silence: understanding the structure and function of small RNAs | Q29622905 | ||
| Optimal design and validation of antiviral siRNA for targeting HIV-1. | Q30365737 | ||
| Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems | Q33933613 | ||
| Gene silencing as an adaptive defence against viruses | Q34084219 | ||
| HTLV-1 structural proteins | Q34345295 | ||
| RNA interference is an antiviral defence mechanism in Caenorhabditis elegans | Q34443971 | ||
| Human T-lymphotropic virus 1: recent knowledge about an ancient infection | Q34610888 | ||
| RNA interference against viruses: strike and counterstrike | Q34655478 | ||
| RNA interference: from basic research to therapeutic applications | Q34657942 | ||
| Human T-Cell Lymphotropic Virus Type I and Neurological Diseases | Q35112026 | ||
| Adult T cell leukemia lymphoma | Q35880693 | ||
| Evidence that RNA silencing functions as an antiviral defense mechanism in fungi | Q35921734 | ||
| HTLV-1 tropism and envelope receptor. | Q36254884 | ||
| Human T-cell leukemia virus type I induces adult T-cell leukemia: from clinical aspects to molecular mechanisms | Q36771229 | ||
| Small-molecule inhibitor which reactivates p53 in human T-cell leukemia virus type 1-transformed cells | Q36845802 | ||
| RNA interference and antiviral therapy. | Q36944914 | ||
| Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs | Q37010585 | ||
| Treatment of adult T-cell leukemia/lymphoma: past, present, and future | Q37032793 | ||
| Repression of tax expression is associated both with resistance of human T-cell leukemia virus type 1-infected T cells to killing by tax-specific cytotoxic T lymphocytes and with impaired tumorigenicity in a rat model | Q37093004 | ||
| The neurology of HTLV-1 infection | Q37371446 | ||
| Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA | Q37614755 | ||
| Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor | Q39597818 | ||
| Prevention of HIV-1 infection in human peripheral blood mononuclear cells by specific RNA interference | Q39687367 | ||
| Overexpression of Aurora A by loss of CHFR gene expression increases the growth and survival of HTLV-1-infected T cells through enhanced NF-kappaB activity | Q39881724 | ||
| Role of human T-cell leukemia virus type I Tax in expression of the human telomerase reverse transcriptase (hTERT) gene in human T-cells | Q39990760 | ||
| Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells | Q40027911 | ||
| Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice | Q40089500 | ||
| Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA. | Q40097069 | ||
| Silencing of HIV-1 gene expression by two types of siRNA expression systems | Q40193835 | ||
| Hepatitis B virus is inhibited by RNA interference in cell culture and in mice | Q40255282 | ||
| Inhibition of Hepatitis B virus gene expression by single and dual small interfering RNA treatment. | Q40397298 | ||
| Local RNA target structure influences siRNA efficacy: systematic analysis of intentionally designed binding regions | Q40432859 | ||
| Tax deregulation of NF-kappaB2 p100 processing involves both beta-TrCP-dependent and -independent mechanisms | Q40525571 | ||
| Modulation of HIV-1 replication by RNA interference | Q40721798 | ||
| siRNA-directed inhibition of HIV-1 infection | Q40727988 | ||
| Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells | Q40735249 | ||
| Inhibition of SARS-CoV replication by siRNA. | Q45206542 | ||
| Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells | Q45869585 | ||
| Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs. | Q50774425 | ||
| P433 | issue | 1 | |
| P921 | main subject | Human T-lymphotropic virus 1 | Q1280388 |
| P304 | page(s) | 92-98 | |
| P577 | publication date | 2011-01-26 | |
| P1433 | published in | Journal of Virological Methods | Q15749961 |
| P1476 | title | Silencing of HTLV-1 gag and env genes by small interfering RNAs in HEK 293 cells. | |
| P478 | volume | 173 |
Search more.